The company has a drug called 3TC effective in an Aids cocktail
mix with Glaxo's drug and maybe even some of Mercs new drug.
It has been very volatile because of much controversity and
misunderstanding. The drug is also very effective against hepatitis
Both potential markets are huge. Still considered untaped yet.
The stock is rated a very agressive buy by Hambrect and Quist.
BCHXF has a composition of matter patent.
Yet Emory university was granted a patent for 3TC.
Biochem Pharm will fight the granting of the patent to
Emory Univ. Because of other patent rights and other
legal matters even if the Emory patent is retained
it will only effect a small % of the profits of BCHXF.
The stock closed at 28 tonight. It sold off on what I
believe to be a buy of 100,000 shares at 29 then several
10,000 share lots hitting the bid at 28. I feel it is
a panic sell at 28 and should be brought here. If it goes lower
still a buy.
Jerry. |
